The Indian Competition Authority provides guidance on treatment of non-compete clause/ obligations in commercial agreements (Hospira Healthcare India / Orchid Chemicals and Pharmaceuticals)

Combinations: CCI provides guidance on treatment of non-compete clause/ obligations in commercial agreements* Facts of the Case Recently, CCI has approved a proposed sale by Orchid Chemicals and Pharmaceuticals Ltd (“OCPL”) of its certain assets to Hospira Healthcare. Under the deal, OCPL has agreed to sell its Betaculum API (Active Pharmaceutical Ingredients) business along with its

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Vaish Associates, Advocates (New Delhi)

Quotation

Man Mohan Sharma, The Indian Competition Authority provides guidance on treatment of non-compete clause/ obligations in commercial agreements (Hospira Healthcare India / Orchid Chemicals and Pharmaceuticals), 21 December 2012, e-Competitions Bulletin December 2012, Art. N° 87763

Visites 36

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues